Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components

Transfusion

Volumn 52, Issue 5, 2012, Pages 936-945

  Sanchez, Rosa ^a,b,c,d   Lee, Tzong Hae ^a,b,c,d   Wen, Li ^a,b,c,d   Montalvo, Leilani ^a,b,c,d   Schechterly, Cathy ^a,b,c,d   Colvin, Camilla ^a,b,c,d   Alter, Harvey J ^a,b,c,d   Luban, Naomi L C ^a,b,c,d   Busch, Michael P ^a,b,c,d  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MOLECULAR MARKER;

ADOLESCENT; ADULT; ARTICLE; BLOOD COMPONENT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; GAMMA IRRADIATION; HUMAN; INJURY SEVERITY; LEUKOCYTE; MAJOR CLINICAL STUDY; MICROCHIMERISM; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECIPIENT; RISK ASSESSMENT; THROMBOCYTE TRANSFUSION; TRANSFUSION ASSOCIATED MICROCHIMERISM; Y CHROMOSOME;

ADULT; BLOOD COMPONENT TRANSFUSION; CHILD; FEMALE; GAMMA RAYS; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANTATION CHIMERA;

EID: 84861079640     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03366.x     Document Type: Article

References (44)

1. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA,. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996; 93: 705-8.
2. Dunsford I, Bowley CC, Hutchison AM, Thompson JS, Sanger R, Race RR,. A human blood-group chimera. Br Med J 1953; 2: 80-1.
3. Adams KM, Nelson JL,. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA 2004; 291: 1127-31.
4. Lee TH, Paglieroni T, Ohto H, Holland PV, Busch MP,. Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. Blood 1999; 93: 3127-39.
5. Lee TH, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W, Owings JT, Holland PV, Busch MP,. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion 2005; 45: 1280-90.
6. Utter GH, Nathens AB, Lee TH, Reed WF, Owings JT, Nester TA, Busch MP,. Leukoreduction of blood transfusions does not diminish transfusion-associated microchimerism in trauma patients. Transfusion 2006; 46: 1863-9.
7. Kruskall MS, Lee TH, Assmann SF, Laycock M, Kalish LA, Lederman MM, Busch MP, Viral Activation Transfusion Study Group. Survival of transfused donor white blood cells in HIV-infected recipients. Blood 2001; 98: 272-9.
8. Reed W, Lee TH, Vichinsky EP, Lubin BH, Busch MP,. Sample suitability for the detection of minor white cell populations (microchimerism) by polymerase chain reaction. Transfusion 1998; 38: 1041-5.
9. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337: 1861-9.
10. Ruhl H, Bein G, Sachs UJ,. Transfusion-associated graft-versus-host disease. Transfus Med Rev 2009; 23: 62-71.
11. Busch MP, Collier A, Gernsheimer T, Carrington JD, Flanigan TP, Kashkari M, Kennedy M, Kumar PN, Lane TA, Mellors JW, Mohandas K, Pollard RB, Viele M, Yomtovian R, Holland PV, McCurdy PR,. The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview. Transfusion 1996; 36: 854-9.
12. Opelz G, Sengar DP, Mickey MR, Terasaki PI,. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253-9.
13. Vamvakas EC,. Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials. Transfusion 1996; 36: 175-86.
14. Vamvakas EC,. Meta-analysis of randomized controlled trials comparing the risk of postoperative infection between recipients of allogeneic and autologous blood transfusion. Vox Sang 2002; 83: 339-46.
15. Vamvakas EC, Blajchman MA,. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21: 327-48.
16. Vamvakas EC, Blajchman MA,. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001; 97: 1180-95.
17. Utter GH, Lee TH, Rivers RM, Montalvo L, Wen L, Chafets DM, Reed WF, Busch MP,. Microchimerism decades after transfusion among combat-injured US veterans from the Vietnam, Korean, and World War II conflicts. Transfusion 2008; 48: 1609-15.
18. Fearon T, Criss VR, Luban NL,. Blood irradiator dosimetry with BANG polymer gels. Transfusion 2005; 45: 1658-62.
19. Akahoshi M, Takanashi M, Masuda M, Yamashita H, Hidano A, Hasegawa K, Kasajima T, Shimizu M, Motoji T, Oshimi K, Mizoguchi H,. A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters. Transfusion 1992; 32: 169-72.
20. Utter GH, Owings JT, Lee TH, Paglieroni TG, Reed WF, Gosselin RC, Holland PV, Busch MP,. Microchimerism in transfused trauma patients is associated with diminished donor-specific lymphocyte response. J Trauma 2005; 58: 925-31. discussion 931-2.
21. Reed WF, Lee TL, Trachtenberg E, Vinson M, Busch MP,. Detection of microchimerism by PCR is a function of amplification strategy. Transfusion 2001; 41: 39-44.
22. Utter GH, Reed WF, Lee TH, Busch MP,. Transfusion-associated microchimerism. Vox Sang 2007; 93: 188-95.
23. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, Lee TH,. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001; 41: 1524-30.
24. Bloemers BL, van Bleek GM, Kimpen JL, Bont L,. Distinct abnormalities in the innate immune system of children with Down syndrome. J Pediatr 2010; 156: 804-9, 809.e1-5.
25. Giannoudis PV,. Current concepts of the inflammatory response after major trauma: an update. Injury 2003; 34: 397-404.
26. Gill RM, Lee TH, Utter GH, Reed WF, Wen L, Chafets D, Busch MP,. The TNF (-308A) polymorphism is associated with microchimerism in transfused trauma patients. Blood 2008; 111: 3880-3.
27. Pelszynski MM, Moroff G, Luban NL, Taylor BJ, Quinones RR,. Effect of gamma irradiation of red blood cell units on T-cell inactivation as assessed by limiting dilution analysis: implications for preventing transfusion-associated graft-versus-host disease. Blood 1994; 83: 1683-9.
28. Dzik S,. Principles of counting low numbers of leukocytes in leukoreduced blood components. Transfus Med Rev 1997; 11: 44-55.
29. Schechter GP, Soehnlen F, McFarland W,. Lymphocyte response to blood transfusion in man. N Engl J Med 1972; 287: 1169-73.
30. Lee TH, Donegan E, Slichter S, Busch MP,. Transient increase in circulating donor leukocytes after allogeneic transfusions in immunocompetent recipients compatible with donor cell proliferation. Blood 1995; 85: 1207-14.
31. Price TH,. Neutrophil and lymphocyte kinetics. In:, Rossi EC, Simon TL, Moss GS, editors. Principles of transfusion medicine. Baltimore (MD): Williams and Wilkins; 1999. p. 281-2.
32. Kamper-Jorgensen M, Ahlgren M, Rostgaard K, Melbye M, Edgren G, Nyrén O, Reilly M, Norda R, Titlestad K, Tynell E, Hjalgrim H,. Survival after blood transfusion. Transfusion 2008; 48: 2577-84.
33. Gauvin F, Champagne MA, Robillard P, Le Cruguel JP, Lapointe H, Hume H,. Long-term survival rate of pediatric patients after blood transfusion. Transfusion 2008; 48: 801-8.
34. Levy O,. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007; 7: 379-90.
35. Spinella PC, Dressler A, Tucci M, Carroll CL, Rosen RS, Hume H, Sloan SR, Lacroix J, Pediatric Acute Lung Injury and Sepsis Investigators Network. Survey of transfusion policies at US and Canadian children's hospitals in 2008 and 2009. Transfusion 2010; 50: 2328-35.
36. New HV, Stanworth SJ, Engelfriet CP, Reesink HW, McQuilten ZK, Savoia HF, Wood EM, Olyntho S, Trigo F, Wendel S, Lin Y, Hume H, Petäjä J, Krusius T, Villa S, Ghirardello S, von Lindern J, Brand A, Hendrickson JE, Josephson CD, Strauss RG, Luban NL, Paul W,. Neonatal transfusions. Vox Sang 2009; 96: 62-85.
37. Neves JF, Marques A, Valente R, Barata D,. Nonlethal, attenuated, transfusion-associated graft-versus-host disease in an immunocompromised child: case report and review of the literature. Transfusion 2010; 50: 2484-8.
38. King KE, Ness PM,. How do we prevent transfusion-associated graft-versus-host disease in children? Transfusion 2011; 51: 916-20.
39. Wang-Rodriguez J, Fry E, Fiebig E, Lee T, Busch M, Mannino F, Lane TA,. Immune response to blood transfusion in very-low-birthweight infants. Transfusion 2000; 40: 25-34.
40. Hutchinson DL, Turner JH, Schlesinger ER,. Persistence of donor cells in neonates after fetal and exchange transfusion. Am J Obstet Gynecol 1971; 109: 281-4.
41. Vietor HE, Hallensleben E, van Bree SP, van der Meer EM, Kaal SE, Bennebroek-Gravenhorst J, Kanhai HH, Brand A, Claas FH,. Survival of donor cells 25 years after intrauterine transfusion. Blood 2000; 95: 2709-14.
42. Marshall CS, Zwerdling T, Dwyre, DM, Montalvo L, Lee TH, Busch MP,. Transfusion associated microchimerism, hemoglobinopathy, and autoimmune disease. Transfusion 2007; 47: 110A-1A.
43. Faist E, Schinkel C, Zimmer S,. Update on the mechanisms of immune suppression of injury and immune modulation. World J Surg 1996; 20: 454-9.
44. Lee TH, Chafets DM, Reed W, Wen L, Yang Y, Chen J, Utter GH, Owings JT, Busch MP,. Enhanced ascertainment of microchimerism with real-time quantitative polymerase chain reaction amplification of insertion-deletion polymorphisms. Transfusion 2006; 46: 1870-8.